$22.09Peak — highest point inside the window, not a realized return
$21.26Window close — end-of-window price, context only
What happened
Partial
Reached 10% of the predicted growth at its peak, without hitting the target.
At window close
-1.6%
realized, from the publication price to the last close inside the window
Peak gain
+2.2%
peak, from the publication price — not a realized return
S&P 500, same window
+0%
SPY over the identical days, dividend-adjusted
Window close
$21.26
last close inside the window, ended November 4, 2026
Peak price
$22.09
peak on August 6, 2026 — not a realized return
Days to target
—
The thesis — published August 6, 2026
Predicted growth
+22%
over the measurement window
Target price
$26.36
the price the thesis aimed for
Entry zone
$20.50 – $21.60
the fair-value band we waited for
Price at publication
$21.61
published August 6, 2026
Confidence
72%
how strongly the data lined up
Timeframe
Short-term (0–3 months)
Innoviva looks cheap compared with its earnings, holds a lot of cash, and has no reported debt. Recent strong earnings suggest the business can perform, and the stock sits near a short-term price floor after a sharp drop, so a rebound is possible. However, weak trading activity, uncertain royalty payments, and concentration of assets make confirmation and repeatability uncertain.
Primary drivers
Stock looks cheap versus earnings
Significant cash on the balance sheet, no reported debt
Earnings have beaten expectations multiple times
Royalties provide regular, scalable cash flow
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Share this receipt
A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.